Beyond the direct targeting of HIF-1α, IL-2 activation can also restore the killing potential of NK cells that have been exposed to hypoxia, allowing for maintained degranulation in response to target multiple myeloma cells, despite hypoxic conditions [54]. Here, IL2 is linked to plasma cell myeloma.